Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
Abstract Background Allopurinol is used to treat hyperuricemia and gout. It is metabolized to oxypurinol by xanthine oxidase (XO), and aldehyde oxidase (AO). Allopurinol and oxypurinol are potent XO inhibitors that reduce the plasma uric acid levels. Although oxypurinol levels show large inter-indiv...
Saved in:
Main Authors: | Yoshitaka Tayama (Author), Kazumi Sugihara (Author), Seigo Sanoh (Author), Katsushi Miyake (Author), Shigeyuki Kitamura (Author), Shigeru Ohta (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
by: Dong-Ryeol Ryu
Published: (2017) -
Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome
by: Masanari Kuwabara, et al.
Published: (2024) -
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
by: Andreas Jordan, et al.
Published: (2018) -
Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor
by: Rosa Maria Vitale, et al.
Published: (2017) -
Oxidized Resveratrol Metabolites as Potent Antioxidants and Xanthine Oxidase Inhibitors
by: Orinamhe G. Agbadua, et al.
Published: (2022)